Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kenneth Bate


  • Director at Aveo Pharmaceuticals Inc. (AVEO), 2020-06-30
  • Director at Genocea Biosciences Inc. (GNCA), 2020-06-19
  • Director at Madrigal Pharmaceuticals Inc. (MDGL), 2020-06-18
  • Director at Catabasis Pharmaceuticals Inc (CATB), 2020-06-12
  • Director at Epizyme Inc. (EPZM), 2020-06-02
  • Director at Vanda Pharmaceuticals Inc. (VNDA), 2017-06-20
  • Director at Biomarin Pharmaceutical Inc (BMRN), 2015-06-18
  • Director at Cubist Pharmaceuticals Inc (CBST), 2015-01-21
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CBST $72.83 1,000 Director 7,914 2014-02-03 Filing
CBST $72.02 5,250 Director 8,914 2014-02-03 Filing
CBST $70.00 10,000 Director 7,914 2014-01-09 Filing
CBST $68.10 2,206 Director 7,914 2013-12-02 Filing
CBST $67.53 10,294 Director 10,120 2013-12-02 Filing